605 related articles for article (PubMed ID: 32793238)
21. Intercellular communication by exosome-derived microRNAs in cancer.
Hannafon BN; Ding WQ
Int J Mol Sci; 2013 Jul; 14(7):14240-69. PubMed ID: 23839094
[TBL] [Abstract][Full Text] [Related]
22. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.
Taylor DD; Gercel-Taylor C
Semin Immunopathol; 2011 Sep; 33(5):441-54. PubMed ID: 21688197
[TBL] [Abstract][Full Text] [Related]
23. Macrophage-derived exosomes in cancers: Biogenesis, functions and therapeutic applications.
Liu J; Wu F; Zhou H
Immunol Lett; 2020 Nov; 227():102-108. PubMed ID: 32888974
[TBL] [Abstract][Full Text] [Related]
24. Exosomes as mediators of immune regulation and immunotherapy in cancer.
Kugeratski FG; Kalluri R
FEBS J; 2021 Jan; 288(1):10-35. PubMed ID: 32910536
[TBL] [Abstract][Full Text] [Related]
25. Tumor-cell-derived microvesicles as carriers of molecular information in cancer.
Martins VR; Dias MS; Hainaut P
Curr Opin Oncol; 2013 Jan; 25(1):66-75. PubMed ID: 23165142
[TBL] [Abstract][Full Text] [Related]
26. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes.
Xunian Z; Kalluri R
Cancer Sci; 2020 Sep; 111(9):3100-3110. PubMed ID: 32639675
[TBL] [Abstract][Full Text] [Related]
27. Exosomes and their roles in immune regulation and cancer.
Greening DW; Gopal SK; Xu R; Simpson RJ; Chen W
Semin Cell Dev Biol; 2015 Apr; 40():72-81. PubMed ID: 25724562
[TBL] [Abstract][Full Text] [Related]
28. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion.
Shao X; Hua S; Feng T; Ocansey DKW; Yin L
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233088
[TBL] [Abstract][Full Text] [Related]
30. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
[TBL] [Abstract][Full Text] [Related]
31. Exosomes: Dynamic Mediators of Extracellular Communication in the Tumor Microenvironment.
Wolf-Dennen K; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():189-197. PubMed ID: 32767243
[TBL] [Abstract][Full Text] [Related]
32. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
Darragh LB; Oweida AJ; Karam SD
Front Immunol; 2018; 9():3154. PubMed ID: 30766539
[TBL] [Abstract][Full Text] [Related]
33. Exosomes: Powerful weapon for cancer nano-immunoengineering.
Pi YN; Xia BR; Jin MZ; Jin WL; Lou G
Biochem Pharmacol; 2021 Apr; 186():114487. PubMed ID: 33647264
[TBL] [Abstract][Full Text] [Related]
34. The role of exosomal lncRNAs in cancer biology and clinical management.
Zhang W; Wang Q; Yang Y; Zhou S; Zhang P; Feng T
Exp Mol Med; 2021 Nov; 53(11):1669-1673. PubMed ID: 34819615
[TBL] [Abstract][Full Text] [Related]
35. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
36. New insights into the biological impacts of immune cell-derived exosomes within the tumor environment.
Shen M; Ren X
Cancer Lett; 2018 Sep; 431():115-122. PubMed ID: 29857125
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
38. Exosomes and cancer: from molecular mechanisms to clinical applications.
Jafari A; Babajani A; Abdollahpour-Alitappeh M; Ahmadi N; Rezaei-Tavirani M
Med Oncol; 2021 Mar; 38(4):45. PubMed ID: 33743101
[TBL] [Abstract][Full Text] [Related]
39. Immune Cell-Derived Extracellular Vesicles - Functions and Therapeutic Applications.
Veerman RE; Güçlüler Akpinar G; Eldh M; Gabrielsson S
Trends Mol Med; 2019 May; 25(5):382-394. PubMed ID: 30853173
[TBL] [Abstract][Full Text] [Related]
40. A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells.
Kareva I
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29027915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
